RC
MDLN

Renaissance Capital’s Medline Inc MDLN Stock Holding History

Renaissance Capital’s Portfolio MDLN Stock Details MDLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.02M Buy
228,828
+78,524
+52% +$3.16M 4.98% 6
2026
Q1 		$6.68M Buy
+150,304
New +$6.64M 4.84% 6

Other funds holding MDLN

CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
HFCIX
H&F Corporate Investors X San Francisco, California $2.8B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Capital's MDLN Position: Q2 2026 in Review

Renaissance Capital increased its Medline Inc (MDLN) stake by 52% in Q2 2026, buying an estimated $3.16M and bringing the position to 228,828 shares worth $9.02M. The position accounts for 4.98% of the portfolio, ranked #6.

Renaissance Capital first reported a position in MDLN in Q1 2026 and has held it in 2 quarters since. 407 funds tracked by Wall St. Rank hold MDLN as of Q2 2026.

  • Renaissance Capital held 228,828 shares of Medline Inc worth $9.02M as of Q2 2026.
  • Renaissance Capital bought 78,524 Medline Inc shares in Q2 2026, an estimated $3.16M.
  • Medline Inc made up 4.98% of Renaissance Capital's portfolio in Q2 2026, its #6 holding.
  • Renaissance Capital first reported a position in Medline Inc in Q1 2026 and has held it in 2 quarters since.
  • 407 funds tracked by Wall St. Rank held Medline Inc as of Q2 2026.

Based on Renaissance Capital's 13F filing for Q2 2026, filed 5 Aug 2026.